MRSN

Mersana Therapeutics

Delisted

MRSN was delisted on the 5th of January, 2026.

49 hedge funds and large institutions have $24.7M invested in Mersana Therapeutics in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 22 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$61K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$3.05M
2 +$492K
3 +$359K
4
SSA
Schonfeld Strategic Advisors
New York
+$350K
5
Morgan Stanley
Morgan Stanley
New York
+$255K

Top Sellers

1 -$1.19M
2 -$464K
3 -$424K
4
BlackRock
BlackRock
New York
-$408K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$395K
Name Holding Trade Value Shares
Change
Change in
Stake
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75